ong-term Insulin vs Liraglutide Effect on Beta-cell Function in Type 1 Diabetes with Residual Insulin Secretio
Not Applicable
- Conditions
- Type 1 diabetes with residual insulin secretion (Slowly Progressive Insulin-Dependent Diabetes millitus, Latent Autoimmune Diabetes in Adults)
- Registration Number
- JPRN-UMIN000006919
- Lead Sponsor
- Kitano Hospital, The Tazuke Kofukai Medical Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patients who did not agree with this study 2. The patients with serious complications 3. The patients with chronic kidney disease higher than stage 4 4. Those who are not approved to be eligible to this study by corresponding researcher or co-researchers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in insulin secretory response to glucagon- and arginine-stimulation test
- Secondary Outcome Measures
Name Time Method Anti GADAb, Glycemic control(HbA1c, FPG/PPG, 7 points blood glucose levels in self-monitoring of blood glucose, Body weight, Hypoglycemia, Total dose of insulin injection per day, Adverse Events (including an abnormal laboratory finding)